Log In
Print
BCIQ
Print
Print this Print this
 

TAK-063

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionOral inhibitor of phosphodiesterase-10A (PDE-10A)
Molecular Target Phosphodiesterase-10A (PDE-10A)
Mechanism of ActionPhosphodiesterase-10 (PDE-10) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today